Abbott Laboratories (BUE:ABT) FFO


BUE:ABT Abbott Laboratories BUE:ABT
68 GF Score
Price ARS36,140.00
GF Value ARS49,721.30
Valuation Modestly Undervalued
View Full Analysis

What is Abbott Laboratories FFO?

FFO (Funds from operations) only applies to REITs.

BUE:ABT
68GF Score
Abbott Laboratories BUE:ABT
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Abbott Laboratories (BUE:ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of ARS36,140.00 is trading 27.3% below its estimated GF Value™ of ARS49,721.30. GuruFocus considers Abbott Laboratories to be Modestly Undervalued.

Key valuation signals for BUE:ABT:

  • FFO:
  • GF Value™: ARS49,721.30 vs. price of ARS36,140.00 (27.3% below fair value)
  • GF Score™: 68/100

No single metric tells the full story. See the BUE:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
68GF Score

Get the complete analysis for BUE:ABT

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS36,140.00
Price
ARS49,721.30
GF Value